Acute leukemia

Role of ABCB1 C1236T, G2677T, and C3435T genetic polymorphisms in the development of acute leukemia in a Chinese population

R. Feng, Zhang, H. X., Zhang, H. G., Zhang, C. F., Feng, R., Zhang, H. X., Zhang, H. G., and Zhang, C. F., Role of ABCB1 C1236T, G2677T, and C3435T genetic polymorphisms in the development of acute leukemia in a Chinese population, vol. 15, p. -, 2016.

We carried out a case-control study to examine the relationship between the ATP-binding cassette subfamily B member 1 (ABCB1) gene polymorphisms C1236T, G2677T, and C3435T and risk of acute leukemia in a Chinese population. Between May 2013 and April 2015, we recruited 164 acute leukemia patients and 285 healthy controls, and determined polymorphism genotypes by polymerase chain reaction-restriction fragment length polymorphism.

Expression and effect of serum interleukin-24 level on bone marrow mononuclear cells in children with acute leukemia

H. R. Cheng, Wu, B. Q., Chen, L., Zhang, Z. X., and Li, B., Expression and effect of serum interleukin-24 level on bone marrow mononuclear cells in children with acute leukemia, vol. 14, pp. 17281-17288, 2015.

To investigate the expression of interleukin-24 (IL-24) in the children with acute leukemia (AL) and its effect on the apoptosis of bone marrow mononuclear cells (BMMNCs) in vitro. Four groups were assessed: acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), non-leukemia, and healthy groups, 20 children in each group. ELISA was used to measure IL-24 serum level. The bone marrow was taken from patients and controls. BMMNCs were isolated and the DNA was analyzed by glucose electrophoresis. Flow cytometry was used to determine BMMNC apoptosis.

Expression of TRAIL and its receptor DR5 and their significance in acute leukemia cells

S. M. Chen, Sun, H., Liu, Y. F., Ma, J., Zhang, Q. T., Zhu, J., and Li, T., Expression of TRAIL and its receptor DR5 and their significance in acute leukemia cells, vol. 14, pp. 18562-18568, 2015.

We investigated the roles of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptor death receptor 5 (DR5) in the onset of acute leukemia and changes in their expression during chemotherapy. Bone marrow samples from 16 patients newly diagnosed with acute leukemia were collected before chemotherapy. Bone marrow samples from patients with non-hematologic malignancies served as the control group. Peripheral blood samples of patients with acute leukemia were also collected before chemotherapy and at 1 and 3 days after chemotherapy.

Subscribe to Acute leukemia